January 13, 2021 | From Life Site News
WASHINGTON, D.C., January 12, 2021 (LifeSiteNews) – The U.S. Supreme Court tonight granted the Trump administration’s request for the reinstatement of the Food and Drug Administration (FDA) rules requiring an in-person doctor visit before a woman obtains abortion pills.
This action allows the FDA to enforce the in-person requirements for the abortion pill under Mifeprex’s Risk Evaluation Mitigation Strategy (REMS) while litigation continues in the Fourth Circuit Court. . . .
Under the guise of the coronavirus outbreak, the American College of Obstetricians and Gynecologists (ACOG) and other pro-abortion groups sued the FDA over its regulations that require doctors writing prescripions for abortion pills see their patients in-person. If abortionists don’t see women in person, there can be a host of complications for the mother as well as the child who is killed.
The abortion pill regime is designed to kill babies during the first 10 weeks of pregnancy, but without seeing the mother in-person for an ultrasound, an abortionst could dispense the pills to women farther along in pregnancy than 10 weeks or who have ectopic pregnancies. . . .
Justices Stephen Breyer, Sonia Sotomayor, and Elena Kagan dissented.
“The majority of American women seeking abortion care [sic] during the first 10 weeks of pregnancy rely on medication abortion,” wrote Sotomayor and Kagan in a joint dissent that played up the danger of the coronavirus, citing the Centers for Disease Control. “Medication abortion involves taking two prescription drugs, mifepristone and misoprostol, which together induce the equivalent of an early miscarriage.” . . .
“Although the COVID–19 pandemic has only worsened since October, the Court now grants the Government’s request,” they lamented. “Due to particularly severe health risks, vastly limited clinic options, and the 10-week window for obtaining a medication abortion, the FDA’s requirement that women obtain mifepristone in person during the COVID–19 pandemic places an unnecessary and undue burden on their right to abortion. Pregnancy itself puts a woman at increased risk for severe consequences from COVID–19. In addition, more than half of women who have abortions are women of color, and COVID–19’s mortality rate is three times higher for Black and Hispanic individuals than non-Hispanic White individuals.” . . .
Although the “public health experts” running the FDA right now support the just-reinstated very small restriction on abortion pills, it is highly unlikely the “public health experts” of a Biden regime will feel the same way.
(Excerpt from Life Site News. Article by Claire Chretien. Photo Credit: Unsplash.)